Cargando…

Short QT interval as a harbinger of an arrhythmogenic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Chevalier, Philippe, Moreau, Adrien, Richard, Sylvain, Janin, Alexandre, Millat, Gilles, Bessière, Francis, Delinière, Antoine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602084/ https://www.ncbi.nlm.nih.gov/pubmed/34820269 http://dx.doi.org/10.1016/j.hrcr.2021.07.010

Ejemplares similares

Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model
por: Reisqs, Jean-Baptiste, et al.
Publicado: (2023)

Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy
por: Moreau, Adrien, et al.
Publicado: (2021)

The PPARγ pathway determines electrophysiological remodelling and arrhythmia risks in DSC2 arrhythmogenic cardiomyopathy
por: Reisqs, Jean‐Baptiste, et al.
Publicado: (2022)

Identification of Cx43 variants predisposing to ventricular fibrillation in the acute phase of ST-elevation myocardial infarction
por: Chevalier, Philippe, et al.
Publicado: (2022)

Novel G1481V and Q1491H SCN5A Mutations Linked to Long QT Syndrome Destabilize the Nav1.5 Inactivation State
por: Plumereau, Quentin, et al.
Publicado: (2020)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
por: Rajinthan, Priyanka, et al.
Publicado: (2022)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu, Hiroaki, et al.
Publicado: (2021)

Multifactorial QT Interval Prolongation and Takotsubo Cardiomyopathy
por: Gysel, Michael, et al.
Publicado: (2014)

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022)

Molecular Approach of Hereditary Arrhythmias, Long QT Syndrome, and Arrhythmogenic Right Ventricular Cardiomyopathy
por: Saat, Hanife, et al.
Publicado: (2022)

Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing
por: Chauveau, Samuel, et al.
Publicado: (2017)

Arrhythmogenic cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2016)

Clinical significance of changes in the corrected QT interval in stress-induced cardiomyopathy
por: Lee, Jung-Hee, et al.
Publicado: (2016)

Pregnancy in arrhythmogenic cardiomyopathy
por: Wichter, Thomas, et al.
Publicado: (2021)

Scarring/arrhythmogenic cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2023)

TRPM4 non-selective cation channel variants in long QT syndrome
por: Hof, Thomas, et al.
Publicado: (2017)

Criteria for short QT interval based on a new QT-heart rate adjustment formula
por: Rabkin, Simon W.
Publicado: (2017)

Comment on “Clinical significance of changes in the corrected QT interval in stress-induced cardiomyopathy”
por: Madias, John E.
Publicado: (2017)

The Measurement of the QT Interval
por: Postema, Pieter G, et al.
Publicado: (2014)

The QT Interval in Research
por: Somberg, John
Publicado: (2021)

Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria
por: Whittaker, Dominic G., et al.
Publicado: (2017)

Effect of QT interval-prolonging drugs taken in pregnancy on the neonatal QT interval
por: Michel, Holger, et al.
Publicado: (2023)

Arrhythmogenic cardiomyopathy as a myogenic disease: highlights from cardiomyocytes derived from human induced pluripotent stem cells
por: Reisqs, J. B., et al.
Publicado: (2023)

Arrhythmogenic right ventricular cardiomyopathy
por: Cho, Yongkeun
Publicado: (2018)

Arrhythmogenic left ventricular cardiomyopathy
por: Mirmomen, Seyedeh Mojdeh, et al.
Publicado: (2020)

Natural History of Arrhythmogenic Cardiomyopathy
por: Mattesi, Giulia, et al.
Publicado: (2020)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2021)

Arrhythmogenic left ventricular cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2022)

What’s New in Arrhythmogenic Cardiomyopathies
por: Çimen, Tolga, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy
por: Dolkar, Tsering, et al.
Publicado: (2022)

Correction: Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria
Publicado: (2019)

Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19
por: Schiavone, Marco, et al.
Publicado: (2022)

Issues in QT interval measurement
por: Lanjewar, Pallavi, et al.
Publicado: (2004)

Measuring the QT interval on the go
por: McIntyre, William F., et al.
Publicado: (2021)

Manual vs. automatic assessment of the QT-interval and corrected QT
por: Neumann, Benjamin, et al.
Publicado: (2023)

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Thiene, Gaetano, et al.
Publicado: (2007)

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
por: Stadiotti, Ilaria, et al.
Publicado: (2017)

Exploring digenic inheritance in arrhythmogenic cardiomyopathy
por: König, Eva, et al.
Publicado: (2017)

Genetic Animal Models for Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qs0tt0r33an6lreferl11biruk